Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Patients with glioblastoma-;the deadliest type of primary brain tumor-;may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response against cancer cells.

Related Keywords

Massachusetts ,United States ,Simon Gritsch ,Mitrajit Ghosh ,Meenal Datta ,Ashwins Kumar ,Emily Henderson ,Gilbert Youssef ,Davida Reardon ,Rakeshk Jain ,Ivyx Chen ,J Bryan Iorgulescu ,Mariac Speranza ,Gordonj Freeman ,Sylvie Roberge ,Sampurna Chatterjee ,Mark Duquette ,Shanmugarajan Krishnan ,Raymondy Huang ,Marthar Neagu ,Xinyue Dong ,Pragya Kumar ,Arleneh Sharpe ,Elizabethm Perez ,Ludwig Cancer Center At Harvard ,Jane Trust Foundation ,National Foundation For Cancer Research ,National Cancer Institute ,Nile Albright Research Foundation ,Massachusetts General Hospital ,Tumor Biology ,Andrew Werk Cook Professor ,Radiation Oncology ,Harvard Medical ,Industry Focus ,Kamila Naxerova ,National Foundation ,Cancer Research ,Trust Foundation ,Ludwig Cancer Center ,Blood ,Blood Pressure ,Rain ,Glioblastoma ,Immunotherapy ,Blood Vessel ,Blood Vessels ,Brain Tumor ,Dancer ,Fell ,Drugs ,Bedema ,Hospital ,Immune Response ,Immunosuppression ,Losartan ,Medical School ,Research ,Humor ,